D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
2951
DELISTED
Flushing Financial
FFIC
| $665K | ﹤0.01% |
49,806
-25,147
| -34% | -$461K |
|
2952
Virtu Financial
VIRT
$5.2B
| $664K | ﹤0.01% |
31,889
-59,882
| -65% | -$1.11M |
|
2953
PUT
PennyMac Financial
PFSI
$4.38B
| $663K | ﹤0.01% |
+30,000
| New | +$966K |
|
|
GPX
2954
DELISTED
GP Strategies Corp.
GPX
| $663K | ﹤0.01% |
101,881
-19,909
| -16% | -$232K |
|
2955
Credicorp
BAP
$30.9B
| $662K | ﹤0.01% |
4,624
-40,096
| -90% | -$7.58M |
|
|
SEE
2956
PUT
DELISTED
Sealed Air
SEE
| $662K | ﹤0.01% |
+26,800
| New | +$875K |
|
2957
PUT
IMAX
IMAX
$2.38B
| $661K | ﹤0.01% |
+73,000
| New | +$1.16M |
|
|
PDCE
2958
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $661K | ﹤0.01% |
106,500
+27,300
| +34% | +$492K |
|
2959
Marcus Corp
MCS
$732M
| $660K | ﹤0.01% |
+53,602
| New | +$1.35M |
|
2960
SI-BONE Inc
SIBN
$737M
| $655K | ﹤0.01% |
+54,816
| New | +$1.01M |
|
2961
LendingTree
TREE
$544M
| $655K | ﹤0.01% |
3,573
+355
| +11% | +$100K |
|
2962
Titan Machinery
TITN
$466M
| $654K | ﹤0.01% |
75,288
-9,964
| -12% | -$113K |
|
2963
UBS Group
UBS
$170B
| $654K | ﹤0.01% |
70,654
+45,193
| +177% | +$521K |
|
2964
PUT
Boston Scientific
BSX
$65.8B
| $653K | ﹤0.01% |
+20,000
| New | +$781K |
|
2965
Hormel Foods
HRL
$13.9B
| $653K | ﹤0.01% |
+14,006
| New | +$637K |
|
2966
PUT
Transocean
RIG
$5.92B
| $653K | ﹤0.01% |
563,200
-1,872,400
| -77% | -$7.31M |
|
2967
Pacific Biosciences
PACB
$422M
| $652K | ﹤0.01% |
213,078
-482,736
| -69% | -$1.98M |
|
2968
Teledyne Technologies
TDY
$30.4B
| $651K | ﹤0.01% |
+2,192
| New | +$753K |
|
2969
CALL
Nutanix
NTNX
$14.9B
| $648K | ﹤0.01% |
41,000
-43,700
| -52% | -$1.23M |
|
2970
CALL
CSX Corp
CSX
$98.6B
| $647K | ﹤0.01% |
33,900
-220,800
| -87% | -$5.16M |
|
|
AVYA
2971
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $647K | ﹤0.01% |
80,000
-55,000
| -41% | -$653K |
|
2972
Sturm, Ruger & Co
RGR
$610M
| $646K | ﹤0.01% |
12,698
+3,315
| +35% | +$163K |
|
2973
PUT
First Solar
FSLR
$21.8B
| $645K | ﹤0.01% |
17,900
-7,700
| -30% | -$366K |
|
2974
Silicom
SILC
$228M
| $645K | ﹤0.01% |
23,879
-1,983
| -8% | -$63K |
|
|
MORF
2975
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $645K | ﹤0.01% |
+43,957
| New | +$737K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.